Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3

Karolina Rembeck, J. Waldenström, Kristoffer Hellstrand, +13

Hepatology

Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3

Karolina Rembeck, Åsa Alsiö, Peer Brehm Christensen, +10

PLoS ONE

Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Transient Elastography in Chronic Hepatitis C Infection

Magdalena Ydreborg, Johan Westin, Karolina Rembeck, +8

PLoS ONE

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

Karolina Rembeck, Cristina Maglio, Martin Lagging, +13

BMC Medical Genetics

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

Åsa Alsiö, Karolina Rembeck, Galia Askarieh, +12

PLoS ONE

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience

J. Waldenström, Martti Färkkilâ, Karolina Rembeck, +15

Scandinavian Journal of Gastroenterology

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

Martin Lagging, Karolina Rembeck, Mads Rauning Buhl, +8

Scandinavian Journal of Gastroenterology